Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology.

MLA

Ballweg, Jean A., et al. “Hyperglycaemia after Stage I Palliation Does Not Adversely Affect Neurodevelopmental Outcome at 1 Year of Age in Patients with Single-Ventricle Physiology.” European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery, vol. 36, no. 4, Oct. 2009, pp. 688–93. EBSCOhost, https://doi.org/10.1016/j.ejcts.2009.04.021.

APA

Ballweg, J. A., Ittenbach, R. F., Bernbaum, J., Gerdes, M., Dominguez, T. E., Zackai, E. H., Clancy, R. R., & Gaynor, J. W. (2009). Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery, 36(4), 688–693. https://doi.org/10.1016/j.ejcts.2009.04.021

Chicago

Ballweg, Jean A, Richard F Ittenbach, Judy Bernbaum, Marsha Gerdes, Troy E Dominguez, Elaine H Zackai, Robert R Clancy, and James William Gaynor. 2009. “Hyperglycaemia after Stage I Palliation Does Not Adversely Affect Neurodevelopmental Outcome at 1 Year of Age in Patients with Single-Ventricle Physiology.” European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery 36 (4): 688–93. doi:10.1016/j.ejcts.2009.04.021.